ArticlePorcine health management2025
First molecular detection of porcine rotavirus B (RVB) in Poland - case study and genome analysis.
Article in Porcine health management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of Rotavirus in Diarrheic Piglets on RVA-Vaccinated and Non-Vaccinated Farms.Pathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn view of its massive financial impact related to increased preweaning mortality and poor growth performance, neonatal diarrhoea in piglets is widely regarded as one of the most common issues in modern swine production. Currently, the diarrhoea of undetermined aetiology arises as a complex diagnostic problem in several pig-rearing countries; therefore, the role of agents with not completely established clinical importance, such as non-group A rotaviruses (RVs), should be taken into consideration in a differential diagnosis procedure. The aim of this study was to report the detection of RVB acting as a potential causative agent of porcine diarrhoea.
resultsThe investigation was conducted in a Polish commercial, high-performing farm with 3,300 sows weaning piglets in weekly batches. For the scope of this research, five 3-day-old dead diarrhoeic piglets were collected. All the animals originated from different litters displaying clinical signs regarded as typical of rotaviral enteritis. Prior to the NGS investigation, all the piglets sampled in our current investigation were tested negative for diarrhoea-associated viruses (RVA, RVC, TGEV, PEDV) using commercially available PCR setups. The NGS data for the faecal sample resulted in 510,843 reads after adapter trimming. 981 reads were assigned at species level to RVB (strain GCZ04) during read classification. The genotype constellation of the strain was found to be typical for swine viruses and the nucleotide identities of the segments of the strain were within the cut off values established for different genotypes. The remaining viral reads were annotated to porcine kobuvirus (PKV) (23 reads). Furthermore, the analysis revealed presence of the following taxa: Qubevirus faecium (334 reads), and Gaprivervirus (1 read).
conclusionsOur study reports the first molecular detection of porcine RVB in faecal samples collected from pigs reared on a commercial swine farm in Poland. Since the material was obtained from clinically affected animals and RVB was proven dominant among viral reads obtained during the NGS investigation, the virus may be considered as a potential causative agent of diarrhoeal disease in suckling piglets. Moreover, our research provides the tenth porcine RVB genome in Europe. The identities and phylogenetic clustering of different segment sequences to those from North America, Asia or Europe may suggest a complex evolutionary history of the Polish strain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.